Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Ascendis Pharma A/S as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 220
- +19 vs. Q2 2024
- Shares held
- 62.6M
- +2.32M (+3.8%) vs. Q2 2024
- Total value
- $9.31B
- +$1.09B (+13.3%) vs. Q2 2024
- New holders
- 44
- 78 more added
- Sold out
- 25
- 69 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 313 | $17.8B |
| Q1 2026 | 274 | $14.3B |
| Q4 2025 | 303 | $13.8B |
| Q3 2025 | 281 | $12.7B |
| Q2 2025 | 248 | $10.9B |
| Q1 2025 | 245 | $10.1B |
| Q4 2024 | 215 | $8.78B |
| Q3 2024 | 220 | $9.31B |
| Q2 2024 | 203 | $8.28B |
| Q1 2024 | 189 | $9.19B |
| Q4 2023 | 185 | $7.59B |
| Q3 2023 | 160 | $5.64B |
| Q2 2023 | 158 | $5.45B |
| Q1 2023 | 164 | $6.54B |
| Q4 2022 | 187 | $8.05B |
| Q3 2022 | 183 | $6.89B |
| Q2 2022 | 168 | $5.88B |
| Q1 2022 | 177 | $7.27B |
| Q4 2021 | 172 | $7.85B |
| Q3 2021 | 166 | $9.24B |
| Q2 2021 | 171 | $7.24B |
| Q1 2021 | 177 | $6.83B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Ascendis Pharma A/S; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 501,690 | $74.9M | 0.06% | +28,241+6.0% | Added |
| BlackRock, Inc. | 536,104 | $80.0M | 0.00% | +536,104 | New |
| FIL Ltd | 640,259 | $95.6M | 0.09% | +197,751+44.7% | Added |
| Spyglass Capital Management LLC | 652,841 | $97.5M | 6.40% | −10,047−1.5% | Reduced |
| Citadel Advisors LLC | 663,924 | $99.1M | 0.10% | +126,162+23.5% | Added |
| Ameriprise Financial Inc | 669,717 | $100.0M | 0.03% | +9,055+1.4% | Added |
| Camber Capital Management LP | 700,000 | $104.5M | 4.06% | +700,000 | New |
| Invesco Ltd. | 1,162,245 | $173.5M | 0.03% | +55,796+5.0% | Added |
| Franklin Resources Inc | 1,459,723 | $187.5M | 0.05% | −625,128−30.0% | Reduced |
| Wellington Management Group LLP | 1,261,480 | $188.4M | 0.03% | −1,351,376−51.7% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,765,042 | $263.5M | 0.16% | +1,734,478+5,674.9% | Added |
| Massachusetts Financial Services Co | 1,866,986 | $278.8M | 0.08% | +155,971+9.1% | Added |
| Capital International Investors | 2,109,390 | $315.0M | 0.06% | +5,092+0.2% | Added |
| Price T Rowe Associates Inc | 2,121,128 | $316.7M | 0.04% | +336,980+18.9% | Added |
| Janus Henderson Group PLC | 4,186,694 | $625.1M | 0.32% | +267,881+6.8% | Added |
| Artisan Partners Limited Partnership | 4,411,111 | $658.6M | 0.99% | +116,082+2.7% | Added |
| FMR LLC | 4,907,846 | $732.8M | 0.04% | −14,709−0.3% | Reduced |
| Avoro Capital Advisors LLC | 4,988,888 | $744.9M | 10.86% | +792,227+18.9% | Added |
| Westfield Capital Management Co LP | 5,133,766 | $766.5M | 3.46% | +170,942+3.4% | Added |
| Ra Capital Management, L.P. | 9,710,428 | $1.45B | 16.72% | −397,972−3.9% | Reduced |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −734,284−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −664,307−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −227,762−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −101,100−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −20,250−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −13,696−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −10,905−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −8,877−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −8,304−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −8,013−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −6,589−100.0% | Sold out |
| Eisler Capital (US) LLC | 0 | $0 | 0.00% | −6,080−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −5,319−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −4,527−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −4,221−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −3,613−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −2,833−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −2,180−100.0% | Sold out |
| Searle & Co. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Gratus Capital LLC | – | – | – | – | Not filed |